Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 9,085-9,096 of 10,592
Behavioral study icon
CompletedNCT00309452

Specialized Treatment Early in Psychosis (STEP)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaBehavioralFrom 16 Years to 45 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02990026

Specialty Mental Health Probation in North Carolina

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralFrom 21 Years to 64 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Addiction
Behavioral study icon
Enrolling By InvitationNCT04040062

Spectral TMS (s-TMS)

This study is looking at care and outcomes for people with depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

In United States
DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Device study icon
CompletedNCT00181831

Spectroscopy in Children and Adolescents With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Bipolarity, ADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 6 Years to 17 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, ADHD
Device study icon
CompletedNCT03433339

Spinal Cord Stimulation for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionDeviceFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Depression
Drug study icon
CompletedNCT00475878

SSRI and Buprenorphine

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Depression
Drug study icon
CompletedNCT00035438

St. John's Wort Vs. Placebo in OCD.

This summary needs review. Please check the official study record and contact the research team for details.

In United States
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Condition
OCD
Drug study icon
CompletedNCT00721955

Staccato Loxapine in Agitated people with Bipolarity

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00628589

Staccato Loxapine in Agitated people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00369577

Staccato Loxapine in Agitation (Proof of Concept)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00444028

Staccato Loxapine Single Dose PK

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.